DNA damage and cytotoxicity induced by β-lapachone: Relation to poly(ADP-ribose) polymerase inhibition

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 401, Issue 1-2, 1998, Pages 55-63

  Vanni, Antonella ^a   Fiore, Mario ^a   De Salvia, Rosella ^a   Cundari, Enrico ^a   Ricordy, Ruggero ^a   Ceccarelli, Roberto ^b   Degrassi, Francesca ^a  

^a CNR   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

lapachone; Alkaline elution; Flow cytometry; Poly(ADP ribose) polymerase; S phase cytotoxicity; Topoisomerase I

Indexed keywords

BETA LAPACHONE; DNA TOPOISOMERASE; NAPHTHOQUINONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLASMID DNA; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DNA DEGRADATION; DNA STRAND BREAKAGE; ENZYME ACTIVITY; FLOW CYTOMETRY; GENOTOXICITY; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION;

ANIMALS; CELL CYCLE; CELL SURVIVAL; CHO CELLS; CRICETINAE; DNA DAMAGE; KINETICS; MUTAGENS; NAPHTHOQUINONES; POLY(ADP-RIBOSE) POLYMERASES; RADIATION-SENSITIZING AGENTS; S PHASE;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; MAMMALIA;

EID: 0032486082     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00273-X     Document Type: Article

References (28)

1. O.G. De Lima, I.L. D'Alburquerque, C.G. De Lima, M.H.D. Maia, Substancias antimicrobianas de plantas superiores, Rev. Inst. Antibiot. Univ. Fed. Pernambuco (Recife) 4 (1961) 3-17.
2. A.R. Schuerch, W. Wehrli, β-Lapachone, an inhibitor of oncornavirus reverse transcriptase and eucaryotic DNA polymerase alfa, Eur. J. Biochem. 84 (1978) 197-205.
3. R.J. Boorstein, A.B. Pardee, β-Lapachone greatly enhances MMS lethality to human fibroblasts, Biochem. Biophys. Res. Comm. 118 (1984) 828-834.
4. D.A. Boothman, S. Greer, A.B. Pardee, Potentiation of halo-genated pyrimidine radiosensitizers in human carcinoma cells by β-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione), a novel DNA repair inhibitor, Cancer Res. 47 (1987) 5361-5366.
5. D.A. Boothman, D.K. Trask, A.B. Pardee, Inhibition of potentially lethal DNA damage repair in human tumor cells by β-lapachone, an activator of topoisomerase I, Cancer Res. 49 (1989) 605-612.
6. C.J. Li, L. Averboukh, A.B. Pardee, β-lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin, J. Biol. Chem. 268 (1993) 22463-22468.
7. B. Frydman, L.J. Marton, J.S. Sun, K. Neder, D.T. Witiak, A.A. Liu, H.M. Wang, Y. Mao, H.Y. Wu, M.M. Sanders, L.F. Liu, Induction of DNA topoisomerase II-mediated DNA cleavage by β-lapachone and related naphthoquinones, Cancer Res. 57 (1997) 620-627.
8. R. Docampo, F.S. Cruz, A. Boveris, R.P.A. Muniz, D.M.S. Esquivel, β-Lapachone enhancement of lipid peroxidation and superoxide formation by sarcoma 180 ascites tumor cells, Biochem. Pharmacol. 28 (1979) 723-728.
9. M.P. Molina Portela, A.O. Stoppani, Redox cycling of β-lapachone and related o-naphthoquinones in the presence of dihydrolipoamide and oxygen, Biochem. Pharmacol. 51 (1996) 275-283.
10. M.P. Molina Portela, S.H. Fernandez Villamil, L.J. Perissinotti, A.O. Stoppani, Redox cycling of o-naphthoquinones in trypanosomatids, superoxide and hydrogen peroxide production, Biochem. Pharmacol. 52 (1996) 1875-1882.
11. F. Degrassi, R. De Salvia, L. Berghella, The production of chromosomal alterations by β-lapachone, an activator of topoisomerase I, Mutat. Res. 288 (1993) 263-267.
12. F. Degrassi, R. De Salvia, C. Tanzarella, F. Palitti, Induction of chromosomal aberrations and SCE by camptothecin, an inhibitor of mammalian topoisomerase I, Mutation Res. 211 (1989) 125-130.
13. S.M. Planchon, S. Wuerzberger, B. Frydman, D.T. Witiak, P. Hutson, D.R. Church, G. Wilding, D.A. Boothman, β-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response, Cancer Res. 55 (1995) 3706-3711.
14. C.J. Li, C. Wang, A.B. Pardee, Induction of apoptosis by β-lapachone in human prostate cancer cells, Cancer Res. 55 (1995) 3712-3715.
15. D.T. Sasaki, S.E. Dumas, E.G. Engelman, Discrimination of viable and non-viable cells using propidium iodide in two color immunofluorescence, Cytometry 8 (1987) 413-420.
16. K.W. Kohn, L.C. Erickson, R.A.G. Ewig, C.A. Friedman, Fractionation of DNA from mammalian cells by alkaline elution, Biochemistry 15 (1976) 4629-4637.
17. A. Lanza, S. Tornaletti, M. Stefanini, H.H. Evans, M. Ricanati, G.C.B. Astaldi Ricotti, A.M. Pedrini, The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases, Carcinogenesis 14 (1993) 1759-1763.
18. A.M. Ferro, B.M. Olivera, Poly(ADP-ribosylation) in vitro, J. Biol. Chem. 257 (1982) 7808-7813.
19. R.C. Benjamin, D.M. Gill, Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA, J. Biol. Chem. 255 (1980) 10502-10508.
20. J.E. Cleaver, W.F. Morgan, Poly(ADP-ribose) polymerase: a perplexing participant in cellular response to DNA breakage, Mutation Res. 257 (1991) 1-18.
21. M.S. Satoh, T. Lindahl, Role of poly(ADP-ribose) formation in DNA repair, Nature 356 (1992) 356-358.
22. E. Ben-Hur, C.C. Chen, E.E. Elkind, Inhibitors of poly(adenosine diphosphoribose) synthetase: examination of metabolic perturbations and enhancement of radiation response in Chinese hamster cells, Cancer Res. 45 (1985) 2123-2127.
23. A.M. Ferro, B.M. Olivera, Poly(ADP-ribosylation) of DNA topoisomerase I from calf thymus, J. Biol. Chem. 259 (1984) 547-554.
24. J. Jongstra-Bilen, M.E. Ittel, C. Niedergang, H.P. Vosberg, P. Mandel, DNA topoisomerase I from calf thymus is inhibited in vitro by poly(ADP-ribosylation), Eur. J. Biochem. 136 (1983) 391-396.
25. D.A. Boothman, N. Fukunaga, M. Wang, Down-regulation of topoisomerase I in mammalian cells following ionizing radiation, Cancer Res. 54 (1994) 4618-4626.
26. M.R. Mattern, S.M. Mong, H.F. Bartus, C.K. Mirabelli, S.T. Crooke, R.K. Johnson, Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells, Cancer Res. 47 (1987) 1793-1798.
27. D.A. Boothman, A.B. Pardee, Inhibition of radiation-induced neoplastic transformation by β-lapachone, Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 4963-4967.
28. P.J. Smith, DNA topoisomerase disfunction: a new goal for anti-tumour chemotherapy, BioEssays 12 (1990) 167-172.